These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21129437)

  • 1. Effects of atomoxetine, desipramine, d-amphetamine and methylphenidate on impulsivity in juvenile rats, measured in a T-maze procedure.
    Bizot JC; David S; Trovero F
    Neurosci Lett; 2011 Feb; 489(1):20-4. PubMed ID: 21129437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test.
    Navarra R; Graf R; Huang Y; Logue S; Comery T; Hughes Z; Day M
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):34-41. PubMed ID: 17714843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats.
    Ruocco LA; Carnevale UA; Treno C; Sadile AG; Melisi D; Arra C; Ibba M; Schirru C; Carboni E
    Behav Brain Res; 2010 Jun; 210(1):99-106. PubMed ID: 20156489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylphenidate reduces impulsive behaviour in juvenile Wistar rats, but not in adult Wistar, SHR and WKY rats.
    Bizot JC; Chenault N; Houzé B; Herpin A; David S; Pothion S; Trovero F
    Psychopharmacology (Berl); 2007 Aug; 193(2):215-23. PubMed ID: 17406857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sub-optimal performance in the 5-choice serial reaction time task in rats was sensitive to methylphenidate, atomoxetine and d-amphetamine, but unaffected by the COMT inhibitor tolcapone.
    Paterson NE; Ricciardi J; Wetzler C; Hanania T
    Neurosci Res; 2011 Jan; 69(1):41-50. PubMed ID: 20934466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of atomoxetine on locomotor activity and impulsivity in the spontaneously hypertensive rat.
    Turner M; Wilding E; Cassidy E; Dommett EJ
    Behav Brain Res; 2013 Apr; 243():28-37. PubMed ID: 23266523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine.
    Tzavara ET; Bymaster FP; Overshiner CD; Davis RJ; Perry KW; Wolff M; McKinzie DL; Witkin JM; Nomikos GG
    Mol Psychiatry; 2006 Feb; 11(2):187-95. PubMed ID: 16231039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimensional analysis of ADHD subtypes in rats.
    Blondeau C; Dellu-Hagedorn F
    Biol Psychiatry; 2007 Jun; 61(12):1340-50. PubMed ID: 17054922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety.
    Heal DJ; Cheetham SC; Smith SL
    Neuropharmacology; 2009 Dec; 57(7-8):608-18. PubMed ID: 19761781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment stabilization in children and adolescents with attention-deficit/hyperactivity disorder: data from the Netherlands.
    Sasané R; Hodgkins P; Meijer W
    Curr Med Res Opin; 2010 Nov; 26(11):2565-74. PubMed ID: 20863165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atomoxetine increases histamine release and improves learning deficits in an animal model of attention-deficit hyperactivity disorder: the spontaneously hypertensive rat.
    Liu LL; Yang J; Lei GF; Wang GJ; Wang YW; Sun RP
    Basic Clin Pharmacol Toxicol; 2008 Jun; 102(6):527-32. PubMed ID: 18346050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys.
    Gasior M; Bergman J; Kallman MJ; Paronis CA
    Neuropsychopharmacology; 2005 Apr; 30(4):758-64. PubMed ID: 15526000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1H MRS-detectable metabolic brain changes and reduced impulsive behavior in adult rats exposed to methylphenidate during adolescence.
    Adriani W; Canese R; Podo F; Laviola G
    Neurotoxicol Teratol; 2007; 29(1):116-25. PubMed ID: 17196789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pay attention to impulsivity: modelling low attentive and high impulsive subtypes of adult ADHD in the 5-choice continuous performance task (5C-CPT) in female rats.
    Tomlinson A; Grayson B; Marsh S; Harte MK; Barnes SA; Marshall KM; Neill JC
    Eur Neuropsychopharmacol; 2014 Aug; 24(8):1371-80. PubMed ID: 24882551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical involvement of dopaminergic neurotransmission in impulsive decision making.
    van Gaalen MM; van Koten R; Schoffelmeer AN; Vanderschuren LJ
    Biol Psychiatry; 2006 Jul; 60(1):66-73. PubMed ID: 16125144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atomoxetine. Attention-deficit/hyperactivity disorder: no better than methylphenidate.
    Prescrire Int; 2010 Feb; 19(105):5-8. PubMed ID: 20455329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneously hypertensive rats do not predict symptoms of attention-deficit hyperactivity disorder.
    van den Bergh FS; Bloemarts E; Chan JS; Groenink L; Olivier B; Oosting RS
    Pharmacol Biochem Behav; 2006 Mar; 83(3):380-90. PubMed ID: 16580713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Behavioral and pharmacological studies of juvenile stroke-prone spontaneously hypertensive rats as an animal model of attention-deficit/hyperactivity disorder].
    Ueno K; Togashi H; Yoshioka M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Feb; 23(1):47-55. PubMed ID: 12690641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abuse liability assessment of atomoxetine in a drug-abusing population.
    Jasinski DR; Faries DE; Moore RJ; Schuh LM; Allen AJ
    Drug Alcohol Depend; 2008 May; 95(1-2):140-6. PubMed ID: 18328639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.